dr t p sahoo | cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
Published 1 year ago • 34 plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
18:34
dr alok gupta | enzalutamide in treatment of mcrpc
-
1:19
comparing abiraterone and docetaxel in prostate cancer treatment
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
0:38
new findings could change the everyday treatment of patients with advanced prostate cancer
-
1:41
dr. oh on abiraterone versus docetaxel in prostate cancer
-
6:42
titan trial
-
1:10
abiraterone: a new therapy for metastatic prostate cancer | memorial sloan kettering
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
1:48
hsp60 as a potential therapeutic for diabetes and its complications
-
11:23
therap study: lu-psma vs. cabazitaxel #asco20 #anzup
-
19:54
ct of the bladder: pearls and pitfalls
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
-
6:02
surgeon chooses tavr
-
1:58
dr. seidman on paclitaxel schedules as adjuvant therapy for breast cancer
-
1:15
proton-panc: proton therapy in adjuvant pancreatic cancer
-
1:24
dr. michael rotkowitz explains the sipuleucel-t treatment process
-
1:10
prostate cancer? causes and prostate cancer risk factors